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Abstract
SM1 is a twelve-amino-acid peptide that binds tightly to the Anopheles salivary gland and inhibits its invasion by
Plasmodium sporozoites. By use of UV-crosslinking experiments between the peptide and its salivary gland target protein,
we have identified the Anopheles salivary protein, saglin, as the receptor for SM1. Furthermore, by use of an anti-SM1
antibody, we have determined that the peptide is a mimotope of the Plasmodium sporozoite Thrombospondin Related
Anonymous Protein (TRAP). TRAP binds to saglin with high specificity. Point mutations in TRAP’s binding domain A
abrogate binding, and binding is competed for by the SM1 peptide. Importantly, in vivo down-regulation of saglin
expression results in strong inhibition of salivary gland invasion. Together, the results suggest that saglin/TRAP interaction is
crucial for salivary gland invasion by Plasmodium sporozoites.
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Introduction
Plasmodium spp., the causative agent of malaria, is responsible for
about 500 million clinical cases and about 2 million deaths every
year, mostly of African children [1]. Furthermore, the number of
cases is increasing [2] indicating that the available means to fight
the disease are insufficient. Unlike the other two major infectious
disease killers-AIDS and tuberculosis-malaria depends on an
intermediate insect vector for transmission to occur. Thus, the
complex life cycle of the parasite in the mosquito constitutes a
potential weak link that could be exploited for malaria control.
Plasmodium transmission is initiated with the ingestion by the
female mosquito, of gametocytes from an infected individual. Soon
after ingestion, gametocytes differentiate into male and female
gametes that mate to produce zygotes within the mosquito midgut.
Within the next day, these differentiate into motile ookinetes that
invade the midgut epithelium. After emerging on the hemocoel
side, ookinetes differentiate into sessile oocysts that mature one or
two weeks later (depending on Plasmodium species) releasing
thousands of sporozoites into the open hemolymph circulation.
Of all mosquito tissues and cell types that the sporozoites come in
contact with, they invade only one: the salivary glands. The
transmission cycle is completed when an infected mosquito bites
another individual releasing some of its sporozoites.
Several lines of evidence suggest that sporozoite invasion of the
salivary gland requires specific receptor-ligand interactions. For
instance, P. knowlesi sporozoites can invade the salivary glands of
Anopheles dirus but not salivary glands of An. freeborni [3]. Inhibition
experiments with polyclonal serum against whole Aedes aegypti
salivary glands and against specific salivary gland epitopes all
suggest the involvement of specific receptors [4–6]. Moreover, a
monoclonal antibody against the 100 kDa salivary gland protein
inhibited invasion of An. gambiae salivary glands by P. yoelii
sporozoites [7]. Recently it was shown that this monoclonal
antibody recognizes a glycosylated homodimer protein made up of
50 kDa subunits, designated saglin [8]. Finally, binding of the
SM1 peptide to An. stephensi salivary glands strongly interfered with
P. berghei sporozoite invasion (see below).
Thrombospondin-related anonymous protein (TRAP) [9] is a
protein expressed in sporozoites and conserved in all Plasmodium
species. TRAP is essential for sporozoite gliding, cell invasion and
in vivo infectivity [10]. TRAP is localized to the parasite
micronemes [11] and becomes surface exposed at the sporozoite’s
anterior tip, particularly upon contact with the host [12]. It is also
released onto the substrate during gliding locomotion [13]. The
extracellular portion of TRAP contains two conserved adhesive
domains: a von Willebrand factor A-domain (‘A-domain’) [14] and
a thrombospondin type I repeat (TSR) [15]. This combination of
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proteins of many apicomplexans and independent lines of
evidence suggest that these proteins have similar functions to
TRAP [13,16–19]. More recent results show that sporozoites
carrying a mutated TRAP domain-A are impaired in salivary
gland invasion but not in gliding motility suggesting that the two
processes are functionally distinct and that the A-domain is
involved in recognition and/or attachment to salivary gland
receptor molecules [20,21].
By use of a phage display library we had previously identified a
peptide, SM1, which binds to the outer surface of anopheline
salivary glands and inhibits sporozoite invasion, most likely
because the peptide binds to and competes for a putative
sporozoite receptor on the surface of the salivary glands [22].
This is true both for the rodent P. berghei parasite [22] and for the
human P. falciparum parasite (unpublished observations) suggesting
that salivary gland invasion of the two parasite species have similar
pathways. However, the precise identity of the putative receptor
and of the sporozoite ligand remained unknown. Here we show
that SM1 is a mimotope of the TRAP domain-A and that SM1
interacts specifically with saglin on the surface of the salivary
gland. Additional evidence suggests that TRAP domain-A directly
interacts with saglin and that this interaction is essential for
sporozoite invasion of the salivary gland.
Results
SM1 binds to a protein moiety on the salivary gland
surface.
The SM1 peptide binds to two quite different epithelia, the
midgut and the salivary gland, which are the two cell types that are
invaded by Plasmodium parasites [22]. It was therefore possible that
the SM1 peptide binds to a carbohydrate that is common to the
two epithelia. In a preliminary test, we tested for the ability of eight
different lectins to bind to salivary glands. Of these, WGA, jacalin,
SBA and ConA bound strongly, DBA and PNA bound moderately
and RCA and UEA bound weakly (Figure S1). When salivary
glands were treated with sodium periodate, binding of WGA
(Figure 1C) and several other lectins (results not shown) was lost,
indicating that this treatment results in effective removal of surface
carbohydrates. Importantly, binding of SM1 was unimpaired by
periodate treatment (Figure 1C), suggesting that SM1 does not
bind to a carbohydrate moiety. Treatment of salivary glands with
three different glycosidases (PNGase and EndoH for N-linked
carbohydrates, and O-glycosidase for O-linked carbohydrates)
confirmed the results obtained with chemical carbohydrate
removal (Figure S2A–C). Interestingly, while SM1 binds poorly
to the proximal lobes [22] (Figure 1C), after carbohydrate removal
SM1 effectively bound to this salivary gland region, indicating that
carbohydrates may mask SM1 binding to the proximal lobes.
To test whether SM1 binds to a protein moiety, we repeated the
assay with protease-treated salivary glands. Whereas protease
treatment did not affect lectin binding, it severely inhibited SM1
binding (Figure 1D and Figure S2 D,E). These results suggest that
SM1 binds to a surface protein.
SM1 conformation mimics that of sporozoite TRAP
domain-A
Inhibition of sporozoite invasion of salivary glands by SM1 raised
the possibility that the peptide shares sequence or structural similarity
with a sporozoite protein involved in salivary gland recognition. Yet,
exhaustive data base searches for Plasmodium proteins with sequence
similarity to SM1 did not reveal any viable candidates. We reasoned
that SM1 peptide conformation (rather than primary sequence) may
be related to that of a sporozoite protein involved in salivary gland
invasion. To test this hypothesis, we generated an anti-SM1 antibody.
Immune (but not pre-immune) anti-SM1 serum specifically recog-
nized an ,95 kDa protein doublet on Western blots of purified
sporozoites but not on blots of a mock-purified fraction from non-
infected guts (Figure 2A). With immunofluorescence assays the anti-
SM1 serum stained permeabilized (Figure 2B, a–c) with a patchy
pattern. A small proportion (2,3%) of the non-permeabilized
sporozoites had a cap-like staining over one of its ends (Figure 2B, d–
f). These staining patterns are typical of apicomplexan micronemal
proteins that are released onto the parasite surface upon target cell
contact, such as Toxoplasma gondii MIC2 [12,16].
To identify the proteins that are recognized by the anti-SM1
antibody we performed 2D electrophoretic analysis with proteins
from an enriched P. berghei sporozoite preparation (Figure 2C). Two
aliquots of 10
6 (samples 1 and 2) and one aliquot of 10
7 (sample 3)
sporozoites from the same purified sporozoite preparation were
fractionatedinparallelby2Dgelelectrophoresis.Gelsfromsamples1
and 2 were blotted onto membranes and incubated with an anti-SM1
antibody (Figure2C) or with pre-immune serum (not shown).Sample
3 was stained with Coomassie Blue (not shown). Three major stained
protein spots (A–C) with mobility of ,9 0k D at h a tr e a c t e dw i t ht h e
anti-SM1 antibody were excised from the stained gel and sequenced
by mass spectrometry. Protein B (Figure 2C) corresponded to the
secreted P. berghei TRAP protein while the other two corresponded to
the Plasmodium cytoplasmic hsp90 protein. SM1 and the domain-A of
P. berghei TRAP share some amino acid sequence similarity (Figure
S3). We produced GST-tagged recombinant TRAP domain-A (and
GST as a control) and determined that TRAP domain-A antibodies
and anti-SM1 antibodies recognize proteins of similar mobility
(Figure 2D). Together, these results indicate that SM1 is a
conformational analog of TRAP domain-A. Additional evidence
supporting this hypothesis is presented below.
Pull-down assays reveal that SM1 binds to the salivary
gland surface protein saglin
To identify salivary gland protein(s) to which SM1 bound, we
used a double-derivatized SM1 peptide that had biotin at the N-
terminus and an UV-crosslinker attached to the phenylalanine (F)
within the 8-amino acid loop formed by the disulphide bond
between cysteines 2 and 11 (Figures 1B and 3A). The derivatized
SM1 was incubated with freshly dissected salivary glands followed
by UV irradiation to activate peptide crosslinking to its target
salivary gland receptor (Figure 3A). The glands were then
solubilized and the peptide, with its crosslinked proteins, was
captured on a streptavidin column. The retained proteins were
then fractionated by gel electrophoresis. The four specific protein
bands (Figure 3B) were excised and microsequenced. The upper
two bands corresponded to the recently described mosquito
Author Summary
Transmission of Plasmodium, the causative agent of
malaria, requires the completion of a complex life cycle
in the mosquito, which includes invasion of the salivary
glands. This invasion depends on the recognition of
mosquito salivary gland surface components by the
parasite. This work demonstrates that interaction between
the salivary-gland-specific surface protein saglin and the
parasite surface protein TRAP is essential for invasion to
occur. A better understanding of the mechanisms used by
the parasite to develop in the mosquito may lead to novel
approaches to intervene with the spread of the disease.
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bands corresponded to the mosquito salivary gland secreted
protein SG1 of unknown function. Figure S3 illustrates the
identification of saglin by LCMS/MS. Saglin has a predicted
secretion signal sequence at its amino terminus and is rich in the
amino acid glutamine (47/412 amino acids or 11.4%) that may be
involved in protein-protein interactions via hydrogen bonds.
Monoclonal antibodies recognizing saglin had previously been
shown to inhibit sporozoite invasion of salivary glands [7].
In vitro interactions of saglin with TRAP domain-A and
SM1
The results presented so far suggested that SM1 mimics the
conformation of TRAP domain-A and that SM1 interacts with
saglin. Further experiments were conducted to verify that these
components interact directly. Figure 4A and 4B present results of
far-western experiments in which bacterial lysates containing
either recombinant saglin or control beta-galactosidase were
fractionated by gel electrophoresis and blotted. The blot in
Figure 4A was incubated with the SM1 peptide and the blot in
Figure 4B was incubated with TRAP domain-A and peptide or
TRAP domain-A binding was detected with their respective
antibodies. Panel 3 of Figure 4A shows that SM1 binds to saglin
and panel 2 of Figure 4B shows that TRAP domain-A binds to
saglin. Binding was specific and was not detected when the control
beta-galactosidase was run on the gel (Figure 4A panel 6 and
Figure 4B panel 5).
Additional evidence was obtained for the direct interaction
between saglin and TRAP domain-A in the following experiment.
Recombinant saglin was captured on wells of a microtiter plate
followed by incubation with recombinant TRAP domain-A. As seen
in Figure 4C, interaction between saglin and TRAP domain-A was
detected only in the complete experiment (bar 2) and not when one of
the steps was omitted, attesting to the specificity of the interaction.
These results confirmed that TRAP domain-A directly interacts with
saglin. In separate experiments, we trapped salivary gland mem-
branes (and ovary membranes as a control) on wells of a microtiter
plate that had been pre-coated with anti-saglin antibodies. TRAP
domain-A bound to salivary gland but not to ovary membranes
(Figure S5), again suggesting tissue specificity of interaction.
Midgut sporozoites bind to saglin
The preceding results raised the possibility that for salivary gland
invasion, sporozoites anchor to saglin on the surface of salivary glands
via its TRAP protein. To provide further evidence for this hypothesis
we incubated purified sporozoites in microtiter plate wells previously
coated with recombinant saglin. The results show that sporozoites
bind to the wells only when they are coated with saglin (Figure 5D),
suggesting a direct interaction between sporozoites and saglin.
TRAP domain-A binds to salivary glands and the SM1
peptide competes for this binding
The findings that the SM1 peptide ‘pulls-down’ saglin from the
salivary gland surface and that anti-SM1 antibodies recognize
Figure 1. SM1 binds to a salivary gland protein. In all experiments the lectin (WGA) was labeled with FITC (green fluorescence) and binding of
the biotinylated SM1 peptide was detected with Texas red-labeled streptavidin (red fluorescence). (A) Schematic diagram of the lifecycle of malaria
parasite in the mosquito vector. After initial development in the midgut lumen, motile ookinetes (ook) cross the midgut epithelium and differentiate
into sessile oocysts (ooc). Mature oocysts release sporozoites (spo) into the hemocoel and these specifically recognize the salivary glands (circled in
the inset) resulting in invasion. (B) SM1 structure. The 12-amino acid SM1 peptide has two cysteine residues at positions 2 and 11 that when
connected by disulphide bond form an 8-amino acid loop. (C) Binding of SM1 to salivary glands does not involve surface carbohydrates. Control salivary
glands treated with buffer without periodate showed strong lectin binding (a). Panels (b–d) show an experimental gland treated with periodate and
then incubated with a mixture of WGA and SM1. WGA bound poorly to this gland [b], indicating efficient removal of carbohydrates, while SM1 bound
strongly (c), indicating that carbohydrate removal did not hinder SM1 binding. A differential interference contrast (DIC) image of the same gland is
shown in (d). (D) Protease treatment abrogates SM1 binding. Salivary glands were treated with 0 (control; a, b), 25 mg/ml (c, d) or 100 mg/ml (e, f) of
trypsin and were incubated with a mixture of SM1 and WGA. Protease treatment interfered with SM1 but not with lectin binding.
doi:10.1371/journal.ppat.1000265.g001
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protein mediates salivary glands invasion by binding to one of its
components. We tested this prediction by incubating recombinant
TRAP domain-A with salivary glands and found that indeed the
protein binds directly to its surface (Figure 4E, panel a). We also
investigated whether this interaction could be competed away with
the SM1 peptide. As seen in Figure 4E (panels a–d), SM1
competed in a dose dependent manner with TRAP domain-A for
binding to salivary glands. At 0.5 mM only partial inhibition was
observed while higher concentrations effectively prevented TRAP
domain-A binding. In a complementary set of experiments, we
demonstrated that binding of TRAP domain-A to the salivary
gland surface effectively prevents SM1 binding (Figure 4F). These
results indicated that the SM1 peptide and TRAP domain-A
compete for the same receptor on the salivary gland surface and
this is most likely saglin.
Mutational analysis of TRAP-saglin interactions
TRAP domain-A contains a MIDAS (metal-ion-dependent
adhesion site) motif that is essential for sporozoite invasion of
salivary glands [10]. In particular, when the critical Thr126 amino
acid is mutated to an alanine, sporozoite invasion of mosquito
salivary glands is strongly (,80%) impaired [21]. However, the
molecular basis for this impairment is not understood. We have
produced a recombinant TRAP domain-A protein carrying the
Thr126-to-alanine mutation (Figure 5A) and shown that the
mutation abrogates the ability of the protein to bind to saglin
(Figure 5B and 5C). In addition, binding of the mutant protein to
mosquito salivary glands was also abrogated (Figure 5D). These
results attest to the specificity of the interaction between TRAP
domain-A and mosquito salivary glands or recombinant saglin.
Saglin is required for sporozoite invasion of salivary
glands
To evaluate the importance of saglin for P. falciparum sporozoite
invasion of salivary glands, we injected mouse anti-saglin
monoclonal antibody into infected An. gambiae mosquitoes at a
time when sporozoites are starting to invade the salivary glands.
Two days later, we assayed the number of sporozoites that had
invaded the salivary glands. As controls, mosquitoes from the same
Figure 2. An anti-SM1 antibody recognizes a protein component of midgut sporozoites. (A) Western blots with the anti-SM1 antibody. The
same number of midguts from Plasmodium-infected (carrying mature oocysts) or non-infected mosquitoes (mock) was used for gradient purification
of sporozoites. Either 5610
5 sporozoites (lanes 1 and 3) or an equivalent amount of material from the mock purification (lanes 2 and 4) was
fractionated by SDS-PAGE and blotted. One blot was incubated with anti-SM1 antibody (immune) and the other with pre-immune serum, as
indicated. The double arrows point to the bands that are specifically detected by the immune serum. (B) Indirect immunofluorescence staining (IFA).
Fixed sporozoites were incubated with anti-SM1 or pre-immune serum followed by incubation with an FITC-labeled (green) secondary antibody.
Nuclei were labeled with DAPI and appear blue. (a–c) Methanol-fixed (permeabilized) midgut sporozoites incubated with anti-SM1 antibody. (d–e)
Paraformaldehyde-fixed (non-permeabilized) midgut sporozoites incubated with anti-SM1 antibody. (g–i) Methanol-fixed (permeabilized) midgut
sporozoites incubated with pre-immune serum. Panel (i) is a DIC image of the same field as (g) and (h). (C) Western blots of 2D gels with the anti-SM1
antibody. Two aliquots of 10
6 (samples 1 and 2) and one aliquot of 10
7 (sample 3) sporozoites from the same enriched sporozoite preparation were
fractionated in parallel by 2D gel electrophoresis. Gels from samples 1 and 2 were blotted onto a membrane and incubated with an anti-SM1
antibody (panel C) or with pre-immune serum (not shown). Sample 3 was stained with Coomassie Blue (not shown). Three protein spots (A–C) with
mobility of ,90 kDa (c.f. panel B) that reacted with the anti-SM1 antibody were excised from the stained gel for protein sequence analysis. (D)
Western blots with anti-TRAP and anti-SM1 antibodies. Equal amounts of recombinant GST (lanes 1 and 3) and GST-tagged recombinant TRAP domain-
A (lanes 2 and 4) proteins were fractionated by SDS-PAGE and the proteins blotted. The blot shown in the left panel was incubated with anti-TRAP
domain-A antibody (the antibody was made against a GST-tagged recombinant protein) and the blot shown on the right panel was incubated with
anti-SM1 antibody. The double arrows point to the TRAP domain-A bands recognized by the both antibodies.
doi:10.1371/journal.ppat.1000265.g002
Mosquito Salivary Gland Invasion
PLoS Pathogens | www.plospathogens.org 4 January 2009 | Volume 5 | Issue 1 | e1000265cohort were injected with an unrelated monoclonal antibody. We
found that the antibody strongly inhibited P. falciparum sporozoite
salivary gland invasion (Figure 6A), suggesting that saglin plays a
central role in this process. Similar results were obtained for
experiments with P. berghei sporozoite invasion (results not shown).
Previous work had shown that the same monoclonal antibody
inhibits salivary gland invasion by the rodent P. yoelii parasite [7].
A possible caveat for the interpretation of these results is that saglin
may not be directly recognized by the sporozoites but rather, that
inhibition is due to steric hindrance by the bulky antibody. To
address this possibility, we used RNA interference to knockdown
saglin expression. Injection of saglin double-stranded (ds) RNA led
to strong decrease of its mRNA abundance and this downregu-
lation was maintained for at least 6 d (Figure 6B). We also used
immunofluorescence assays to follow the abundance of saglin
protein on the salivary gland surface after saglin dsRNA injection
and found that there was a strong decline in protein abundance in
saglin dsRNA-injected mosquitoes but not in GFP dsRNA-
injected control mosquitoes (Figure 6C). Finally, we determined
the effect of saglin depletion on the ability of sporozoites to invade
the salivary gland. Saglin dsRNA, or GFP dsRNA as a control,
were injected into mosquitoes infected with P. falciparum and the
number of sporozoites that had invaded the salivary gland was
assayed 6 d later. Sporozoite invasion of salivary glands in
mosquitoes injected with saglin dsRNA was inhibited by 89 to
98% relative to GFP dsRNA-injected mosquitoes (Figure 6D).
These results show that saglin plays a crucial role in sporozoite
invasion of salivary glands.
Discussion
Salivary gland invasion is an essential step of the Plasmodium life
cycle in its mosquito vector. Circumstantial evidence suggests that
this invasion process is mediated by specific receptor-ligand
interactions. Here we report that the salivary gland protein saglin
is a receptor and that the sporozoite protein TRAP is a ligand in
this invasion. Both proteins had independently been implicated in
the process of invasion [7,20,21]. Saglin is expressed specifically on
the salivary gland distal lobes, which is the region invaded by
sporozoites [7]. Coincidently, the SM1 dodecapeptide
(PCQRAIFQSICN) that was originally isolated from a phage
display library screen for phages that bind to the surface of salivary
glands also binds specifically to the salivary gland distal lobes.
Moreover, inhibition of sporozoite invasion by SM1 binding to the
salivary glands [22] raised the possibility that SM1 competes with
a sporozoite protein for a receptor on the salivary gland surface
(Figure 7). Here we report that SM1 binds to saglin on the
mosquito salivary gland and that an anti-SM1 antibody recognizes
the sporozoite protein TRAP (Figure 7). These findings led to the
concept that the two proteins may interact, a hypothesis that was
verified by further in vitro and in vivo experiments. Our results
indicate that both P. falciparum and P. berghei use saglin as a
receptor. The fact that the SM1 peptide blocks salivary gland
invasion of both P. berghei [22] and P. falciparum (unpublished
results) makes it likely that both parasite species use TRAP
domain-A as a ligand for invasion.
As a search of available databases did not reveal any Plasmodium
protein with similarity to the peptide, we reasoned that SM1
conformation, rather than primary amino acid sequence, is related
to a sporozoite protein. Several observations supported this
assumption. First, SM1 binding to salivary glands was abolished
by the reduction of the disulphide bond between the two cysteines
(unpublished observation). Second, an anti-SM1 antibody recog-
nizes sporozoite TRAP (Figure 2A and 2D). Third, TRAP
domain-A binds to salivary glands and this binding can be
competed by the SM1 peptide (Figure 4E and 4F). TRAP-related
proteins mediate cell-cell and cell-matrix interactions in a wide
variety of biological systems [23]. Moreover, TRAP is an essential
protein for gliding motility and sporozoite invasion of mosquito
salivary glands [10]. Sporozoites harboring mutations in TRAP
domain-A (the part of the protein that resembles SM1) preserve
Figure 3. Pull-down of salivary gland proteins that interact with SM1. (A) Schematic diagram of the pull-down approach. A double-
derivatized SM1 peptide, with a biotin residue (yellow pentagon) at the N-terminus and a UV-crosslinking residue (green star) attached to a
phenylalanine residue in the loop (‘F’ in Figure 1B) was incubated in vitro with freshly dissected salivary glands and washed. After shining UV to
promote crosslinking of the peptide to the protein to which it was bound, the salivary glands were lysed and the peptide with the crosslinked protein
was captured on streptavidin beads. The beads were washed and the retained proteins were fractionated by SDS-PAGE (panel B). (B) Gel
electrophoresis of proteins captured on the streptavidin beads. Materials recovered from a pull-down experiment illustrated in panel A were
fractionated by SDS-PAGE under reducing conditions and the gel was stained with Coomassie Blue. Lane 1, Materials eluted from streptavidin beads
that were not incubated with any proteins. The stained bands are presumed to be bead-derived contaminants. Lane 2, Complete experiment, except
that the crosslinking step was omitted. Lane 3, complete experiment, including the crosslinking step (same number of salivary glands as in Lane 2).
The four arrows point to protein bands consistently observed only in the complete experiment.
doi:10.1371/journal.ppat.1000265.g003
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Like TRAP, adhesive domains of CTRP and WARP also mediate
ookinete invasion of the mosquito midgut epithelial cells [18,24–
26]. TRAP domain-A harbors an important module termed metal
ion-dependent adhesion site (MIDAS). Within this module
threonine (T126) and aspartate (D157) are conserved in all
Plasmodium species. In a vertebrate model system, mutation of
these residues to alanines prevent divalent cation ( Mg
2+ or Mn
2+)
coordination and A-domain binding to its ligand, without affecting
A-domain folding [27]. We showed that the T126-to-Ala mutation
Figure 4. In vitro and in vivo protein interactions. (A) SM1 binding to saglin on protein blots. Blots from bacteria carrying a plasmid encoding
either histidine-tagged saglin (experimental; panels 1–4) or histidine-tagged ß-galactosidase (control; panels 5–6) were produced from proteins
recovered either before (U) or after (I) induction of recombinant protein synthesis. Panel 1: Experimental blot incubated with anti-histidine antibody.
Panel 2: Experimental blot incubated with anti-saglin monoclonal antibody. Panel 3: Experimental blot first incubated with the SM1 peptide (10 mg/
ml) and then probed with the anti-SM1 antibody followed by incubation with an alkaline phosphatase-tagged secondary antibody. Panel 4:
Experimental blot incubated with a linear SM1 peptide and probed with anti-SM1 antibody. In the linear peptide the two cysteines were substituted
by alanines. In separate experiments the linear peptide was unable to bind to salivary glands (not shown). Panel 5: Control blot probed with anti-
histidine antibody. Panel 6: Control blot first incubated with the SM1 peptide (10 mg/ml) and then probed with the anti-SM1 antibody. The mobility
of recombinant saglin is indicated by an arrow in Panel 1. (B) TRAP domain-A binding to saglin on protein blots. Blots from bacteria carrying a plasmid
encoding either histidine-tagged saglin (experimental; panels 1–3) or histidine-tagged ß-galactosidase (control; panels 4–5) were produced from
proteins recovered either before (U) or after (I) induction of recombinant protein synthesis. Panel 1: Experimental blot incubated with anti-histidine
antibody; Panel 2: Experimental blot first incubated with recombinant TRAP domain-A protein (2.5 mg/ml) and then probed with anti-TRAP domain-A
antibody, followed by incubation with an alkaline phosphatase-tagged secondary antibody; Panel 3: Same as Panel 2, except that incubation with
anti-TRAP domain-A antibody was omitted; Panel 4: Control blot probed with anti-histidine antibody; Panel 5: Control blot subjected to the same
treatment as described for Panel 2. The mobility of recombinant saglin is indicated by an arrow in panel 1. (C) In vitro interaction between saglin and
TRAP domain-A. Recombinant TRAP domain-A was incubated in wells of an ELISA plate that had been previously coated with recombinant histidine-
tagged saglin. The wells were washed and TRAP binding was quantified using a TRAP antibody followed by incubation with an alkaline phosphatase-
tagged secondary antibody. Results of the colorimetric alkaline phosphatase reaction are reported. (1) Well not coated with recombinant saglin. (2)
Complete protocol. (3) Incubation with TRAP omitted. (4) Incubation with anti-TRAP antibody omitted. (5) Incubation with secondary antibody
omitted. (D) Sporozoites bind to saglin in vitro. Purified midgut sporozoites were incubated in wells of an ELISA plate that had been previously coated
with recombinant histidine-tagged saglin. The wells were washed and sporozoite binding was quantified by use of an anti-CS antibody followed by
incubation with an alkaline phosphatase-tagged secondary antibody. Results of the colorimetric alkaline phosphatase reaction are reported. (1) Well
not coated with recombinant saglin. (2) Complete protocol. (3) Incubation with sporozoites omitted. (4) Incubation with anti-CS antibody omitted. (5)
Incubation with secondary antibody omitted. (E) SM1 competes with TRAP domain-A for binding to salivary glands. Fixed salivary glands were first
incubated with no (a), 0.5 (b), 5 mM (c) or 50 mM (d) of non-biotinylated SM1 peptide followed by incubation with 50 nM of recombinant TRAP
domain-A. TRAP domain-A binding was detected by incubation with an anti-TRAP antibody followed by incubation with a FITC-labeled secondary
antibody. Note that the SM1 peptide effectively competes with TRAP domain-A for binding to salivary glands. (F) Reverse competition: TRAP domain-A
competes with SM1 for binding to salivary glands. Fixed salivary glands were first incubated with no (a), 20 nM (b), 200 nM (c) or 2 mM (d) of
recombinant TRAP domain-A protein followed by incubation with biotinylated SM1 peptide (5 mM). Peptide binding was detected by incubation with
FITC-labeled streptavidin. Note that the protein effectively competes with the SM1 peptide for binding to salivary glands.
doi:10.1371/journal.ppat.1000265.g004
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results suggest that TRAP domain-A interaction with salivary
glands is mediated by binding to saglin. Alignment of SM1 to the
amino acid sequence of domain-A revealed that 6 out of 8 amino
acids in the SM1 loop between the two cysteines loosely aligned
within a region of the MIDAS domain (Figure S4).
We used a benzophenone photophore to crosslink SM1 to the
salivary gland protein(s) with which it interacts. This photo-
crosslinker has several advantages for the study of peptide-protein
interactions: (a) it is chemically more stable than other photo-
activatablereagents;(b) itreactspreferentiallywith C–Hbondseven
in the presence of water; (c) it is compatible with peptide synthesis
methodology; and d) it has a broad 300–600 nm action spectrum
[28,29]. Initial experiments with a SM1 peptide carrying the
benzophenone moiety on the C-terminal end were not successful
butchangingitspositiontothe phenylalanineintheSM1loopledto
the identificationof saglin. We presume that this is because the SM1
loop fits into a receptor pocket, bringing the crosslinking agent into
close proximity of receptor amino acids [30].
SM1 peptide pull-down assays identified two candidate salivary
gland proteins, saglin and an SG1-like protein. Saglin and the
SG1-like candidate protein share only 20% sequence similarity.
SG1 belongs to a family encoding a complex of high molecular
weight proteins among which is a candidate receptor [6]. The
possible role of the SG1 candidate protein identified in this study
in sporozoite invasion of salivary glands remains to be determined.
Saglin was previously identified from the analysis of a monoclonal
antibody against salivary glands that effectively inhibits P. yoelii
sporozoite invasion of An. gambiae salivary glands [7]. The
following evidence supports the concept that saglin is present on
Figure 5. Mutational analysis of TRAP-saglin interactions. (A) Diagram of the TRAP protein and the Thr126 to Ala mutation in the MIDAS
domain. (B) Binding of recombinant wild type or mutant TRAP domain-A to saglin. Saglin was captured on wells of a nickel-coated plate and wild type
or mutant recombinant TRAP domain-A were added to the wells, incubated and washed. Bound TRAP domain-A was detected by incubation with
anti-TRAP domain-A antibody followed by an alkaline phosphatase-conjugated secondary antibody. (1) Wild type TRAP domain-A; (2) Point mutant
TRAP domain-A; (3) No TRAP protein added. (C) Direct visualization of the binding of wild type and mutant TRAP domain-A protein to recombinant
saglin. Histidine-tagged saglin was immobilized on Ni-agarose beads, washed and allowed to bind to the purified wild type or mutant TRAP domain-
A recombinant protein. Beads were washed and incubated with anti-domain-A antibody. Detection was done after incubation with Alexa Flour-568-
conjugated anti-rabbit IgG (red). (a) Wild type TRAP domain-A; (b) Point mutant TRAP domain-A; (c) No TRAP protein added. Panels (d), (e) and (f)
show light microscopic images of the fields to their left. (D) Binding of recombinant wild type and mutant domain-A to salivary glands. Fixed salivary
glands were incubated with wild type or mutant TRAP domain-A protein, washed and incubated with anti-TRAP domain-A antibody. Detection was
with anti-rabbit IgG conjugated to Alexa Flour-488 (green). (a) Wild type TRAP domain-A; (b) Point mutant TRAP domain-A; (c) No TRAP protein
added. The lower panels (d, e, f) show light microscopic images of the fields on top (a, b, c, respectively).
doi:10.1371/journal.ppat.1000265.g005
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Immuno-electronmicrographs by Brennan et al. [7] established
that saglin is present at this location. 2) Injection of anti-saglin
antibody (but not of a control antibody) into the hemocoel of living
mosquitoes strongly inhibits sporozoite invasion (Figure 6A). These
results are only compatible with the presence of saglin on the
salivary gland surface facing the hemocoel. The saglin gene is
predicted to encode a 50 kDa glycoprotein harboring a signal
sequence at the N-terminus [8]. However, no transmembrane
domain or GPI consensus domain could be identified in the
deduced amino acid sequence of the protein. There is precedent
for surface proteins without transmembrane domains, such as
enolase [31] and the IL2 receptor [32]. However, the mechanisms
of surface attachment by such proteins are not well understood.
Glutamines can promote protein-protein interactions through
hydrogen bond formation [33] and it is possible that the relative
high abundance of glutamine residues in saglin perform this
function. The resolution of previously published immunoelectron-
micrographs [7] is not sufficient to determine whether saglin is
part of the salivary gland surface or of the basal lamina.
There is evidence that other sporozoite proteins also play a role
in salivary gland invasion. The synthetic peptide (KLKQP) from
the circumsporozoite (CS) protein region I inhibits P. berghei
sporozoite salivary gland invasion [34] but the receptor of this
peptide has not been identified. Parasites harboring a deletion of
CS region II lost their gliding motility and infectivity of the salivary
gland [35] but how region II interacts with the salivary gland
surface is unknown. Another micronemal protein, MABEL, is also
expressed on the sporozoite surface. MABEL knockout parasites
showed a reduction in the salivary gland infectivity [36] but no
salivary gland MABEL receptor has been identified.
This work provides compelling evidence for a central role that
the interaction between Anopheles saglin and Plasmodium TRAP
plays in sporozoite invasion of the salivary gland. It should be
emphasized however that sporozoite invasion of the salivary gland
is a complex process [37] and that the interactions identified in this
study represent only one of many necessary steps. Whereas the
road to a complete understanding of the molecular basis of
invasion is likely to be long, elucidation of these mechanisms may
lead to novel approaches to intervene with the spread of malaria.
Materials and Methods
Mosquitoes
Colonies of An. gambiae (G-3 strain) and An.stephensi (Dutch
strain) were established from colonies maintained at the Labora-
Figure 6. Sporozoites interact with saglin and this interaction is essential for salivary gland invasion in vivo. (A) Inhibition of P.
falciparum sporozoite invasion of An. gambiae salivary glands by anti-saglin antibody. Either anti-saglin monoclonal antibody [1.5,2 mg, bar 2] or an
equivalent amount of an unrelated antibody [control; bar 1] was injected into the haemocoel of 50 P. falciparum-infected An. gambiae female
mosquitoes. At 48 h after injection the salivary glands of 22 to 30 surviving mosquitoes were dissected and the number of sporozoites determined. A
95% inhibition was observed in this experiment (p-value, ,0.0001). The inhibition in a second experiment (not shown) was 94% (p-value, ,0.0001).
(B) Down-regulation of saglin mRNA abundance by RNA interference. Either control double-stranded GFP RNA (C) or double-stranded saglin RNA was
injected into the hemocoel of An. gambiae female mosquitoes and salivary glands were dissected on days 3 (D3) and 6 (D6) after injection, as
indicated. Saglin mRNA abundance was assessed by semi-quantitative PCR using ribosomal protein S7 mRNA primers as controls. (C) Down-regulation
of saglin protein abundance by RNA interference. Double-stranded GFP RNA (control; panels a–f) or double-stranded saglin RNA (experimental, panels
g–l) was injected into the hemocoel of female An. gambiae mosquitoes and salivary glands were dissected after 1 d (a, b, g, h), 3 d (c, d, i, j) or 6 d (e,
f, k, l) for immunofluorescence assays (IFA) with an anti-saglin antibody. The panels pair fluorescent images to the left and DIC images of the same
gland to the right. (D) Inhibition of sporozoite salivary gland invasion after down-regulation of saglin expression. Approximately 50 P. falciparum-
infected An. gambiae mosquitoes were injected with GFP (1) or saglin (2) dsRNA. Salivary glands were dissected from each of 15,18 surviving
mosquitoes and the number of sporozoites determined. Inhibition was 89% (p-value ,0.0008). The inhibition in a second experiment (not shown)
was 97% (p-value ,0.0001).
doi:10.1371/journal.ppat.1000265.g006
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Infectious Diseases, National Institute of Health, Bethesda).
Larvae were reared on dry cat food. Adults were maintained on
10% sucrose solution at 2761uC and 8065% relative humidity
with a 14h/10h light/dark cycle.
Parasites
P. falciparum strain NF54 gametocyte cultures were maintained
as described [38]. Gametocyte-rich cultures were fed to female An.
gambiae using a glass membrane feeder. P. berghei strain ANKA 2.34
was maintained by passage in Swiss Webster mice [39,40].
Lectins
The following FITC-labeled lectins were purchased from
Vector Laboratories (California]: wheat germ agglutinin (WGA),
jacalin, soybean agglutinin (SBA), concanavalin A (ConA), Dolichos
biflorus agglutinin (DBA), peanut agglutinin (PNA), Ricinus communis
agglutinin (RCA) and Ulex europaeus agglutinin (UEA).
Derivatized peptides and anti-peptide antibody
The biotinylated SM1 peptide was synthesized by Genemed
Synthesis (South San Francisco, California). For immunizations,
the asparagine residue of the original SM1 peptide sequence was
changed to lysine (K) [PQRAIFQSICN/K] for conjugation to
Keyhole Limpet Hemocyanin (KLH) using the glutaraldehyde
method [41]. The final conjugate was purified by gel filtration and
used to immunize rabbits (Biosynthesis Inc., Lewisville, Texas,
USA). A double-derivatized (photocrosslinker and biotin) SM1
peptide was synthesized by Biosynthesis Inc. using a Bpa (p-
benzoyl -L- phenylalanine) photocrosslinker residue that was
incorporated into the SM1 peptide at the phenylalanine residue
[29]. After synthesis the peptide was cyclized at the cysteine
residues and biotin was added at the N-terminal end. Binding
activity of the biotinlyated circular peptide to mosquito salivary
glands was verified by immunofluorescence assays [22].
Chemical carbohydrate removal from salivary glands
Salivary glands were dissected and incubated in periodate buffer
(50 mM sodium acetate, 100 mM NaCl, pH 5.5) for 1 h at room
temperature before treatment [42], and then transferred to
periodate solution (50–100 mM) for 12 h at 4uC in the dark.
After treatment, glands were thoroughly washed in PBS and fixed
in 4% paraformaldehyde overnight at 4uC. Removal of surface
sugars was confirmed on sample salivary glands using eight
different FITC-labeled lectins: WGA, SBA, ConA, jacalin, RCA,
PNA, UEA, and DBA.
Enzymatic carbohydrate removal from salivary glands
Salivary glands were treated with 20 mU PNGase F (Prozyme,
California), 5 mU Endo H or 5 mU O-glycosidase (Roche applied
Figure 7. Schematic diagram of the presumed interaction among the various proteins used in this study. (A) Invasion of salivary glands
requires the interaction between the Anopheles salivary gland surface protein saglin with the Plasmodium secreted protein TRAP. (B) The SM1peptide
also interacts with saglin because its conformation mimics that of TRAP. In the presence of SM1 all saglin sites are occupied, thus preventing saglin-
TRAP interactions and interfering with sporozoite invasion. (C) Because the conformations of SM1 and TRAP are related, an anti-SM1 antibody also
recognizes TRAP. This relationship led to the identification of TRAP.
doi:10.1371/journal.ppat.1000265.g007
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phosphate with 0.1% sodium azide for PNGase; 50 mM sodium
acetate pH 6.0 for Endo H; and phosphate buffer pH 7.4 for O-
glycosidase. All enzyme treatments were done overnight at room
temperature in 50 ml final volume and in the presence of a
protease inhibitor cocktail. After enzymatic digestion, salivary
glands were washed several times in PBS buffer and fixed in 4%
paraformaldehyde overnight at 4uC. Removal of surface sugars
was confirmed on sample salivary glands using the FITC-
conjugated lectins jacalin (for N-linked glycosidase) and WGA
(for O-linked glycosidase).
Purification of midgut sporozoites
Midgut sporozoites were purified by a method modified from
Barreau et al. [4]. An. stephensi mosquitoes were fed on P. berghei
infected mice (3–5% parasitemia, 0.2–0.5% gametocytemia, and
exflagellation rate 1 to 2 per field at 406 magnification). Fed
mosquitoes were collected and kept at 19uC with 10% sucrose. On
day 15, mosquito midguts were dissected and loosely homogenized
with a plastic pestle in PBS, and cell debris were removed by
passing through a glass wool column. Sporozoites that passed
through the column were concentrated by gentle centrifugation
and washed several times in PBS. The final pellet was layered on a
cushion of 6.4% Ficoll (Pharmacia, Texas) and 10% Hypaque
(Sigma) and centrifuged at 4,000 g for 15 min at room
temperature. A fraction65 mm from the cushion interface was
recovered and the sporozoites were washed in PBS. Sporozoite
numbers were determined using a hemocytometer.
2D gel electrophoresis and Western blot analysis
Proteins from Ficoll-Hypaque-purified midgut P. berghei sporo-
zoites were separated by two-dimensional gel electrophoresis AS
DESCRIBED [43,44]. Three identical gels were run in parallel,
two for blotting and a third to recover proteins for sequencing by
tandem mass spectrometry. One of the blots was incubated with
the anti-SM1 antibody (1:1000 dilution), and another one with
preimmune serum for 1 h at room temperature, washed and then
incubated with alkaline phosphatase-conjugated anti-rabbit IgG
secondary antibody. The third gel was stained with Coomassie
Blue. Stained spots corresponding to the anti-SM1 positive
proteins were excised, washed and digested with trypsin prior to
LC-MS/MS analysis as described below in the Mass Spectrometry
(MS) analysis section.
Far-Western blotting
Bacteria carrying protein expression plasmids were induced or
not with arabinose (0.2%). After induction, cells were grown for
another 4 h at room temperature and an aliquot of each culture
(equal number of cells) was centrifuged. The final pellet was
resuspended in 20 ml of sample buffer, and lysed by boiling. The
samples were centrifuged again and the soluble proteins were
fractionated by electrophoresis in a 10% SDS-PAGE before
transferring onto PVDF membrane (Millipore). After transfer,
membranes were washed with several changes in TBST buffer
(150 mM NaCl, 20 mM Tris-HCl,10 mM MgCl2 and 0.1%
Tween-20, pH 7.5), blocked in TBST with 4% BSA, and
incubated with biotinylated SM1 peptide (10 mg/ml) or recombi-
nant TRAP domain A (2.5 mg/ml) in blocking buffer. After
incubation, blots were washed in TBST and incubated either with
alkaline phosphatase(AP)-labeled streptavidin (peptide blots) or
with anti-TRAP domain-A antibody (1:1000,dilution) in blocking
buffer for 1 h followed by incubation with AP-conjugated anti-
rabbit IgG (1:5000 dilution, Promega). Blots were then washed in
TBST several times and 3 times with TBS followed by incubation
with the substrate solution (NBT,BCI P, solution, Western Blue
stabilized substrate for Alkaline Phosphatase (Promega). After
visualizing the bands, color reaction was stopped with stop solution
(1 mM EDTA, 10 mM Tris-HCl, pH 8.0). The final blot was air
dry and pictures were taken.
Peptide pull-down assays
Salivary glands were dissected and kept ice-cold in the presence
of protease inhibitors before washing thoroughly with several
changes of PBS to remove cell debris and other contaminating
materials. The glands were then incubated in a shallow chamber
with the double-derivatized SM1 peptide in PBS (10 mg/ml) for
1 h at 4uC in the dark. Glands were washed to remove unbound
peptide, transferred to another ice-cold shallow chamber, and
exposed to UV light for 30 min using a hand-held UV lamp
(240 nm wave length) held at a distance of 1 cm from the glands.
The glands were then transferred to a microcentrifuge tube,
centrifuged briefly, resuspended in lysis buffer (250 mM KAc,
10 mM MgAc2, 50 mM HEPES, pH 7.4, 0.1% NP40) and
homogenized in the presence of a protease inhibitor cocktail. The
lysate was clarified by centrifugation at 26,000 g for 1 h and the
supernatant was collected [45]. Approximately 100 mlo fa
streptavidin-agarose bead suspension (Molecular probes, S-951)
pre-washed in binding buffer (lysis buffer without NP40) was
added to the supernatant and incubated on a rotary shaker at
room temperature for 1 h. The beads were then washed several
times by centrifugation to remove unbound proteins followed by
addition of SDS-PAGE lysis buffer and boiling for 3 min. The
lysate was fractionated by electrophoresis under reducing
conditions on a 10% acrylamide-SDS gel and stained with
Coomassie Blue. The spots corresponding to proteins that reacted
with the SM1 antibody were excised, washed and digested with
trypsin prior to LC/MS/MS analysis as described below [46,47].
MS analysis
The digested sample was loaded online onto a fused silica
capillary column (12 mm of YMC gel ODS-A). The peptides were
separated with a linear gradient elution from 95% mobile phase A
to 45% mobile phase B [90% acetonitrile with 10% H2O, 0.4%
acetic acid, and 0.005% heptafluorobutyric acid (vol/vol)] in
40 min. A potential of 2.7 kV was applied to the emitter in the ion
source. The mass spectra were acquired on a Micromass-Waters
(Manchester, U.K.) quadrupole time-of-flight (Q-TOF) API-US
mass spectrometer equipped with a nanoelectrospray ion source
(Proxeon Biosystems, Odense, Denmark). The acquisition and the
deconvolution of data were performed on a MassLynx Windows
NT PC data system (version 4). All spectra were obtained in the
positive-ion mode. The processed tandem MS spectra were
searched against the NCBI non-redundant protein database.
Searches were performed with Mascot version 1.9 [48].
Blocking sporozoite invasion with anti-saglin antibody
Starting 10 days after feeding An. gambiae mosquitoes on a P.
berghei-infected mouse, 5 to 10 mosquitoes were dissected daily and
checked for sporozoite invasion of salivary glands. As soon as the
first infected salivary gland was detected, sometime between day
14 and day 16, 1.5 to 2.0 mg (total ascites protein) of anti-saglin
monoclonal 2A3 antibody supernatant [7] or the same amount of
unrelated control antibody (normal mouse ascites) in Aedes saline
[49] was injected into the hemocoel. At 48 h after injections,
salivary glands were dissected and transferred to a tube containing
100 ml of PBS, and homogenized to liberate the sporozoites. These
were collected by centrifugation at 6,000 RPM for 5 min, the
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counted using a hemocytometer.
Expression and purification of recombinant TRAP
domain-A and saglin proteins
The TRAP domain-A and the TSR-plus domain were
expressed as GST fusion proteins and purified according to
Jethwaney et al. [27]. Full-length saglin (GenBank accession #
AAW31598) was cloned, expressed and purified according to
Guzman et al. [50]. Briefly, a 1.2 kb fragment of Saglin was
amplified using the forward (59-CACCATGTCACGTTTGCC-
CACTGTACTGTTGCTC-39) and reverse (59-AAAGCCG-
GACGACTTGCGCGACTCGCTCAGATA-39) primers and
cloned into the pBAD expression vector (Invitrogen). Induction
was done with arabinose and the expressed protein (His-tagged at
the C-terminus) was purified using a nickel column.
Site-directed mutagenesis
The Thr126-to-Ala TRAP domain-A point mutation was
generated with the QuickChange Site-Directed mutagenesis kit
(Stratagene). Briefly supercoiled plasmid DNA (10 ng) was
annealed with two complementary primers containing the
mutation Threonine 126 to Alanine (T126 to A ) : 59-
CACCACTTGGTACTGCAAATTTAACGGAGTGC-39 and
59-GCACTCGTTAAATTTGCAGTACCATGTGGTG-39, and
amplified for up to 15 cycles. The amplified product was digested
with Dpn1 and transformed in XL1Blue supercompetent cells.
The mutant protein was expressed in BL21(DE3) host cells and
purified as described by Jethwaney et al [27].
Immunofluorescence assays
Fixed salivary glands were incubated with wild type and mutant
TRAP domain A, (2.5 mg/ml), washed, blocked and incubated
with anti-TRAP domain-A antibody. Detection was done with
anti-rabbit IgG conjugated with Alexa Flour-488.
Histidine-tagged saglin (2 mg/ml) was immobilized on Ni-NTA
agarose beads, washed and allowed to bind to the purified wild
type and the mutant TRAP domain A recombinant protein
(2.5 mg/ml) in binding buffer (25 mM, Tris-HCl, 0.15 mM NaCl,
and 8.0 mM MnCl2, pH 7.2) for 1 h at room temperature. Beads
were washed and incubated with anti-domain-A antibody.
Detection was done after incubation with Alexa Flour-568-
conjugated anti-rabbit IgG
RNA interference
A 400 bp fragment from the 59 region of the saglin gene was
amplified using a modified primer pair that incorporates the T7
primer sequences at their 59 ends (forward: T7+ 59-AGCGT-
TAGTGCCGAGACGATGAAA-39; reverse: T7+ 59-
TTCGTTTCGCCGATCGCAATGTTC-39). Another 530 bp
fragment close to the 39 end of the saglin coding region was also
amplified using T7-modified primers (forward: T7+ 59-AA-
CATTGCGATCGGCGAAACGAAG-39; reverse: T7+ 59-
GGCCGATAAACTGCTCGCAAATGT-39). PCR products
were cleaned with chroma spin columns (Stratagene, Texas) and
double-stranded RNA (dsRNA) was synthesized and purified with
the Ambion Mega-script kit (Ambion, Texas) according to the
manufacturer’s protocol. GFP control dsRNA was synthesized and
purified as previously described [51]. Initial experiments using 200
or 400 ng of double stranded saglin RNA proved ineffective in
down-regulating saglin expression. However, with 2.5 mgo f
dsRNA per mosquito [52] down-regulation was effective. The
dsRNAs were dissolved in Aedes saline (150 mM NaCl, 4 mM
KCl, 3 mM CaCl2, 1.8 mM NaHCO3, 0.6 mM MgCl2, and
25 mM HEPES pH 7.0) [49]. Mosquito mortality due to injection
of saglin dsRNA and GFP dsRNA was similar.
Starting on day 7, the salivary glands of 5 P. falciparum-infected
An. gambiae mosquitoes were dissected daily and checked for the
presence of sporozoites. About 2–2.5 mg of saglin or GFP dsRNA
was injected into the hemocoel on the day when sporozoite
invasion of the salivary glands was first observed (usually between
day 14 and 16). Salivary glands were dissected 6 days after dsRNA
injection and sporozoites were counted using a hemacytometer.
Supporting Information
Figure S1 Binding pattern of 8 different lectins. Fixed salivary
glands were incubated with FITC-labeled lectins and binding was
detected by fluorescent microscopy. For each gland, a fluorescent
image is shown in the upper panel and a DIC image in the lower
panel.
Found at: doi:10.1371/journal.ppat.1000265.s001 (4.59 MB TIF)
Figure S2 Effects of glycosidase and protease treatments of
salivary glands on SM1 peptide binding. Treatments: (A) N-
glycosidase (PNGPase), (B) O-linked glycosidase and (C) EndoH.
Control (a,b) and treated (c,d & e) glands were incubated with a
mixture of jacalin and SM1. DIC images of the control and treated
glands are shown in b and e. Fluorescence due to jacalin binding is
green and SM1 binding is red.
Found at: doi:10.1371/journal.ppat.1000265.s002 (4.57 MB TIF)
Figure S3 Identification of SAGLIN by LCMS/MS analysis. (A)
Total Ion Chromatogram (TIC) obtained from an LC-MS/MS
run of the peptides derived from in-gel trypsin digestion of a SDS-
PAGE upper band (see Figure 3B, arrows). (B) Mass spectrum of a
small section of the TIC shows two doubly-charged ions (indicated
by arrows) corresponding to saglin peptides that elute approxi-
mately at 24 and 28 minutes. (C,D) Product ion MS/MS spectrum
of the doubly charged ions at m/z 511.32 and m/z 602.85
corresponding to the peptide sequences QLYDDLVR and
EDLPVYQANR respectively, that matched the saglin protein.
Found at: doi:10.1371/journal.ppat.1000265.s003 (0.40 MB TIF)
Figure S4 Schematic of the Plasmodium TRAP protein and
alignment of domain-A amino acids with the SM1 peptide.
Previous work [21] has determined that threonine (T) 126 and
aspartate (D) 157 in the MIDAS region of domain-A are crucial
for salivary gland invasion. SP: signal peptide; TSR: throbospon-
din type I repeat; TM: transmembrane domain; Pf: P. falciparum;
Pg: P. gallinaceum; Pk: P. knowlesi; Pv: P. vivax; Py: P. yoelii; Pb: P.
berghei. Adapted from [53].
Found at: doi:10.1371/journal.ppat.1000265.s004 (0.32 MB TIF)
Figure S5 Interaction between salivary gland membrane-bound
saglin with recombinant TRAP domain-A. Wells from a 96-well
plate were coated with anti-saglin monoclonal antibody (10 mg/ml
ascites). Crude midgut or ovary membranes (prepared as in [54];
equal protein amount) were captured onto the coated wells and
washed to remove excess membranes. Wells were blocked and
incubated with recombinant TRAP domain-A protein (2.5 mg/ml)
followed by incubation with rabbit anti-domain-A antibody
(1:1000 dilution). The wells were then incubated with alkaline
phosphatase-conjugated goat anti-rabbit secondary antibody
(1:5000 dilution). After washing, the wells were incubated with a
chromogenic alkaline phosphatase substrate to quantify the
amount of secondary antibody bound. The graph shows results
with the complete protocol with salivary gland (SG) membranes
(first bar from the left), complete protocol with ovary (Ov)
membranes (second bar), protocol with SG membranes but with
Mosquito Salivary Gland Invasion
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with SG membranes but omitting incubation with recombinant
domain-A protein (fourth bar).
Found at: doi:10.1371/journal.ppat.1000265.s005 (0.11 MB TIF)
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